Patents by Inventor Karen Glatt

Karen Glatt has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOSITIONS, KITS, AND METHODS FOR IDENTIFICATION, ASSESSMENT, PREVENTION, AND THERAPY OF CERVICAL CANCER
    Publication number: 20120264625
    Abstract: The invention relates to nucleic acid molecules and proteins associated with cervical cancer including pre-malignant conditions such as dysplasia. Compositions, kits, and methods for detecting, characterizing, preventing, and treating human cervical cancers are also provided.
    Type: Application
    Filed: October 14, 2011
    Publication date: October 18, 2012
    Applicant: Millennium Pharmaceuticals, Inc.
    Inventors: John E. Monahan, Xumei Zhao, Yan Chen, Karen Glatt, Shubhangi Kamatkar
  • NOVEL GENES, COMPOSITIONS, KITS, AND METHODS FOR IDENTIFICATION, ASSESSMENT, PREVENTION AND THERAPY OF CERVICAL CANCER
    Publication number: 20120064548
    Abstract: The invention relates to newly discovered nucleic acid molecules and proteins associated with cervical cancer including pre-malignant conditions such as dysplasia. Compositions, kits, and methods for detecting, characterizing, preventing, and treating human cervical cancers are provided.
    Type: Application
    Filed: October 12, 2011
    Publication date: March 15, 2012
    Applicant: MILLENNIUM PHARMACEUTICALS, INC.
    Inventors: Robert Schlegel, Yan Chen, Xumei Zhao, John E. Monahan, Shubhangi Kamatkar, Manjula Gannavarapu, Karen Glatt, Sebastian Hoersh
  • Genes, compositions, kits, and methods for identification, assessment, prevention and therapy of cervical cancer
    Patent number: 8062892
    Abstract: The invention relates to newly discovered nucleic acid molecules and proteins associated with cervical cancer including pre-malignant conditions such as dysplasia. Compositions, kits, and methods for detecting, characterizing, preventing, and treating human cervical cancers are provided.
    Type: Grant
    Filed: June 14, 2010
    Date of Patent: November 22, 2011
    Assignee: Millennium Pharmaceuticals, Inc.
    Inventors: Robert Schlegel, Yan Chen, Xumei Zhao, John E. Monahan, Shubhangi Kamatkar, Manjula Gannavarapu, Karen Glatt, Sebastian Hoersch
  • COMPOSITIONS, KITS, AND METHODS FOR IDENTIFICATION, ASSESSMENT, PREVENTION, AND THERAPY OF BREAST CANCER
    Publication number: 20110092388
    Abstract: The invention relates to newly discovered nucleic acid molecules and proteins associated with breast cancer. Compositions, kits, and methods for detecting, characterizing, preventing, and treating human breast cancers are provided.
    Type: Application
    Filed: November 23, 2010
    Publication date: April 21, 2011
    Applicants: MILLENNIUM PHARMACEUTICALS, INC., Board of Regents, The University of Texas system
    Inventors: JAMES LILLIE, Manjula Gannavarapu, Karen Glatt, Sebastian Hoersch, Shubhangi Kamatkar, Maureen Mertens Hattersley, John E. Monahan, Vickesh Myer, Youzhen Wang, Yong Yao Xu, Xumei Zhao, Rachel E. Meyers, Robert C. Bast, JR., Gabriel N. Hortobagyi, Lajos Pusztai
  • Genes, compositions, kits, and methods for identification, assessment, prevention and therapy of cervical cancer
    Patent number: 7846737
    Abstract: The invention relates to newly discovered nucleic acid molecules and proteins associated with cervical cancer including pre-malignant conditions such as dysplasia. Compositions, kits, and methods for detecting, characterizing, preventing, and treating human cervical cancers are provided.
    Type: Grant
    Filed: August 25, 2006
    Date of Patent: December 7, 2010
    Assignee: Millennium Pharmaceuticals, Inc.
    Inventors: Robert Schlegel, Yan Chen, Xumei Zhao, John E. Monahan, Shubhangi Kamatkar, Manjula Gannavarapu, Karen Glatt, Sebastian Hoersch
  • NUCLEIC ACID MOLECULES AND PROTEINS FOR THE IDENTIFICATION, ASSESSMENT, PREVENTION, AND THERAPY OF OVARIAN CANCER
    Publication number: 20100291068
    Abstract: The invention relates to newly discovered nucleic acid molecules and proteins associated with ovarian cancer. Compositions, kits, and methods for detecting, characterizing, preventing, and treating human ovarian cancers are provided.
    Type: Application
    Filed: March 8, 2010
    Publication date: November 18, 2010
    Applicants: MILLENNIUM PHARMACEUTICALS, INC., Board of Regents, The University of Texas System
    Inventors: Wilson O. Endege, Donna Ford, Manjula Gannavarapu, Karen Glatt, Sebastian Hoersch, Shubhangi Kamatkar, John E. Monahan, Robert Schlegel, Yong Yao Xu, Xumei Zhao, Robert C. Bast, JR., Gordon B. Mills, Karen Lu
  • NOVEL GENES, COMPOSITIONS, KITS, AND METHODS FOR IDENTIFICATION, ASSESSMENT, PREVENTION AND THERAPY OF CERVICAL CANCER
    Publication number: 20100291616
    Abstract: The invention relates to newly discovered nucleic acid molecules and proteins associated with cervical cancer including pre-malignant conditions such as dysplasia. Compositions, kits, and methods for detecting, characterizing, preventing, and treating human cervical cancers are provided.
    Type: Application
    Filed: June 14, 2010
    Publication date: November 18, 2010
    Applicant: MILLENNIUM PHARMACEUTICALS, INC.
    Inventors: Robert Schlegel, Yan Chen, Xumei Zhao, John E. Monahan, Shubhangi Kamatkar, Manjula Gannavarapu, Karen Glatt, Sebastian Hoersch
  • Nucleic acid molecules and proteins for the identification, assessment, prevention, and therapy of ovarian cancer
    Patent number: 7799518
    Abstract: The invention relates to newly discovered nucleic acid molecules and proteins associated with ovarian cancer. Compositions, kits, and methods for detecting, characterizing, preventing, and treating human ovarian cancers are provided.
    Type: Grant
    Filed: October 7, 2004
    Date of Patent: September 21, 2010
    Assignees: Millennium Pharmaceuticals, Inc., Board of Regents, University of Texas System
    Inventors: Wilson O. Endege, Donna Ford, Manjula Gannavarapu, Karen Glatt, Sebastian Hoersch, Shubhangi Kamatkar, John E. Monahan, Robert Schlegel, Yong Yao Xu, Xumei Zhao
  • COMPOSITIONS, KITS, AND METHODS FOR IDENTIFICATION, ASSESSMENT, PREVENTION, AND THERAPY OF BREAST CANCER
    Publication number: 20100105051
    Abstract: The invention relates to newly discovered nucleic acid molecules and proteins associated with breast cancer. Compositions, kits, and methods for detecting, characterizing, preventing, and treating human breast cancers are provided.
    Type: Application
    Filed: September 25, 2009
    Publication date: April 29, 2010
    Applicants: MILLENNIUM PHARMACEUTICALS, INC., BOARD OF REGENTS, THE UNIVERSITY OF TEXAS
    Inventors: JAMES LILLIE, MANJULA GANNAVARAPU, KAREN GLATT, SEBASTIAN HOERSCH, SHUBHANGI KAMATKAR, MAUREEN MERTENS HATTERSLEY, JOHN E. MONAHAN, VICKESH MYER, YOUZHEN WANG, YONG YAO XU, XUMEI ZHAO, RACHEL E. MEYERS, ROBERT C. BAST, JR., GABRIEL N. HORTOBAGYI, LAJOS PUSZTAI
  • Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer
    Patent number: 7705120
    Abstract: The invention relates to newly discovered nucleic acid molecules and proteins associated with breast cancer. Compositions, kits, and methods for detecting, characterizing, preventing, and treating human breast cancers are provided.
    Type: Grant
    Filed: June 21, 2002
    Date of Patent: April 27, 2010
    Assignees: Millennium Pharmaceuticals, Inc., Board of Regents, University of Texas System
    Inventors: James Lillie, Manjula Gannavarapu, Karen Glatt, Sebastian Hoersch, Shubhangi Kamatkar, Maureen Mertens, Hattersley, John E. Monahan, Vickesh Myer, Youzhen Wang, Yongyao Xu, Xumei Zhao, Rachel E. Meyers, Robert C. Bast, Jr., Gabriel N. Hortobagyi, Lajos Pusztai
  • COMPOSITIONS, KITS, AND METHODS FOR IDENTIFICATION, ASSESSMENT, PREVENTION, AND THERAPY OF BREAST CANCER
    Publication number: 20100075325
    Abstract: The invention relates to nucleic acid molecules and proteins associated with breast cancer. Compositions, kits, and methods for detecting, characterizing, preventing, and treating human breast cancers are provided.
    Type: Application
    Filed: September 11, 2009
    Publication date: March 25, 2010
    Applicants: MILLENNIUM PHARMACEUTICALS, INC., Board of Regents, The University of Texas System
    Inventors: John E. Monahan, Sebastian Hoersch, Dustin L. Anderson, Wilson O. Endege, Donna Ford, Karen Glatt, Bella O. Gorbatcheva, Shubhangi Kamatkar, Yong Yao Xu, Manjula Gannavarapu, Xumei Zhao, Robert Schlegel, Maureen Mertens Hattersley, Robert C. Bast, JR., Gabriel N. Hortobagyi, Lajos Pusztai
  • Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer
    Patent number: 7601505
    Abstract: The invention relates to nucleic acid molecules and proteins associated with breast cancer. Compositions, kits, and methods for detecting, characterizing, preventing, and treating human breast cancers are provided.
    Type: Grant
    Filed: May 26, 2004
    Date of Patent: October 13, 2009
    Assignees: Millennium Pharmaceuticals, Inc., Board of Regents, The University of Texas Systems
    Inventors: John E. Monahan, Sebastian Hoersch, Dustin L. Anderson, Wilson O. Endege, Donna Ford, Karen Glatt, Bella O. Gorbatcheva, Shubhangi Kamatkar, Yong Yao Xu, Manjula Gannavarapu, Xumei Zhao, Robert Schlegel, Maureen Mertens, Robert C. Bast, Jr., Gabriel N. Hortobagyi, Lajos Pusztai
  • Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer
    Publication number: 20080311573
    Abstract: The invention relates to newly discovered nucleic acid molecules and proteins associated with breast cancer. Compositions, kits, and methods for detecting, characterizing, preventing, and treating human breast cancers are provided.
    Type: Application
    Filed: June 25, 2007
    Publication date: December 18, 2008
    Applicants: MILLENNIUM PHARMACEUTICALS, INC., Board of Regents, The University of Texas System
    Inventors: James Lillie, Manjula Gannavarapu, Karen Glatt, Sebastian Hoersch, Shubhangi Kamatkar, Maureen Mertens, John E. Monahan, Vickesh Myer, Youzhen Wang, Yongyao Xu, Xumei Zhao, Rachel E. Meyers, Robert C. Bast, JR., Gabriel N. Hortobagyi, Lajos Pusztai, Funda Meric, Aysegul Sahin, Gordon B. Mills
  • Compositions, kits, and methods for identification, assessment, prevention, and therapy of cervical cancer
    Publication number: 20080286781
    Abstract: The invention relates to nucleic acid molecules and proteins associated with cervical cancer including pre-malignant conditions such as dysplasia. Compositions, kits, and methods for detecting, characterizing, preventing, and treating human cervical cancers are also provided.
    Type: Application
    Filed: January 24, 2008
    Publication date: November 20, 2008
    Applicant: Millennium Pharmaceuticals, Inc.
    Inventors: John E. Monahan, Xumei Zhao, Yan Chen, Karen Glatt, Shubhangi Kamatkar
  • Novel genes, compositions, kits, and methods for identification, assessment, prevention and therapy of cervical cancer
    Publication number: 20070003990
    Abstract: The invention relates to newly discovered nucleic acid molecules and proteins associated with cervical cancer including pre-malignant conditions such as dysplasia. Compositions, kits, and methods for detecting, characterizing, preventing, and treating human cervical cancers are provided.
    Type: Application
    Filed: August 25, 2006
    Publication date: January 4, 2007
    Applicant: MILLENNIUM PHARMACEUTICALS, INC.
    Inventors: Robert Schlegel, Yan Chen, Xumei Zhao, John Monahan, Shubhangi Kamatkar, Manjula Gannavarapu, Karen Glatt, Sebastian Hoersh
  • Genes, compositions, kits and methods for identification, assessment, prevention, and therapy of cervical cancer
    Patent number: 7125663
    Abstract: The invention relates to newly discovered nucleic acid molecules and proteins associated with cervical cancer including pre-malignant conditions such as dysplasia. Compositions, kits, and methods for detecting, characterizing, preventing, and treating human cervical cancers are provided.
    Type: Grant
    Filed: June 12, 2002
    Date of Patent: October 24, 2006
    Assignee: Millenium Pharmaceuticals, Inc.
    Inventors: Robert Schlegel, Yan Chen, Xumei Zhao, John E. Monahan, Shubhangi Kamatkar, Manjula Gannavarapu, Karen Glatt, Sebastian Hoersh
  • Genes, compositions, kits, and methods for identification, assessment, prevention, and therapy of prostate cancer
    Publication number: 20060068425
    Abstract: The invention relates to newly discovered nucleic acid molecules and proteins associated with prostate cancer including pre-malignant conditions. Compositions, kits, and methods for detecting, characterizing, preventing, and treating human prostate cancers are provided.
    Type: Application
    Filed: August 12, 2005
    Publication date: March 30, 2006
    Applicant: MILLENNIUM PHARMACEUTICALS, INC.
    Inventors: John Monahan, Shubhangi Kamatkar, Sebastian Hoersch, Bella Gorbatcheva, Karen Glatt, Donna Ford, Wilson Endege, Dustin Anderson
  • Nucleic acid molecules and proteins for the identification, assessment, prevention, and therapy of ovarian cancer
    Publication number: 20050214831
    Abstract: The invention relates to newly discovered nucleic acid molecules and proteins associated with ovarian cancer. Compositions, kits, and methods for detecting, characterizing, preventing, and treating human ovarian cancers are provided.
    Type: Application
    Filed: February 4, 2005
    Publication date: September 29, 2005
    Applicant: MILLENNIUM PHARMACEUTICALS, INC.
    Inventors: John Monahan, Manjula Gannavarapu, Sebastian Hoersch, Shubhangi Kamatkar, Steven Kovats, Rachel Meyers, Michael Morrissey, Peter Olandt, Ami Sen, Petter Veiby, Gordon Mills, Robert Bast, Karen Lu, Rosemarie Schmandt, Xumei Zhao, Karen Glatt
  • Novel genes, compositions, kits, and methods for identification, assessment, prevention, and therapy of prostate cancer
    Publication number: 20050191673
    Abstract: The invention relates to newly discovered nucleic acid molecules and proteins associated with prostate cancer including pre-malignant conditions. Compositions, kits, and methods for detecting, characterizing, preventing, and treating human prostate cancers are provided.
    Type: Application
    Filed: February 4, 2005
    Publication date: September 1, 2005
    Applicant: MILLENNIUM PHARMACEUTICALS , INC.
    Inventors: Robert Schlegel, John Monahan, Wilson Endege, Manjula Gannavarapu, Bella Gorbatcheva, Sebastian Hoersch, Shubhangi Kamatkar, Angela Quinn, Karen Glatt, Xumei Zhao, Dustin Anderson
  • Nucleic acid molecules and proteins for the identification, assessment, prevention, and therapy of ovarian cancer
    Publication number: 20050153313
    Abstract: The invention relates to newly discovered nucleic acid molecules and proteins associated with ovarian cancer. Compositions, kits, and methods for detecting, characterizing, preventing, and treating human ovarian cancers are provided.
    Type: Application
    Filed: October 7, 2004
    Publication date: July 14, 2005
    Applicant: MILLENNIUM PHARMACEUTICALS, INC.
    Inventors: Wilson Endege, Donna Ford, Manjula Gannavarapu, Karen Glatt, Sebastian Hoersch, Shubhangi Kamatkar, John Monahan, Robert Schlegel, Yong Xu, Xumei Zhao